Endpoints News 生物医药· Kyle LaHucik·· 15 天前AI 评分20
Caldera 和 Evommune 签署中国特许权协议
Caldera, Evommune sign China licensing deals for autoimmune drugs
AI 导读
Caldera 和 Evommune 近日与中国签署特许权协议,进一步推动自身免疫疾病药物在中国的市场布局。
正文
The biopharma industry was already on pace for one China deal per week for the entire year. Now, another two biotechs have …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news